Novartis Ag (NVS) Net Income towards Common Stockholders (2009 - 2026)
Novartis Ag (NVS) recorded Net Income towards Common Stockholders of $3.26 billion in Q2 2026, down 19.2% from $4.04 billion a year earlier and down 11.2% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
On a TTM basis, Novartis Ag's Net Income towards Common Stockholders came in at $15.78 billion as of Jun 30, 2026, down 13.2% year-over-year; for FY2025, it came in at $13.98 billion, up 4.2% from FY2024.
- Annual Net Income towards Common Stockholders has a five-year compound annual growth rate of 11.6% (FY2020 to FY2025).
- Across earlier years, Net Income towards Common Stockholders came in at $13.43 billion in FY2024 (-9.6%), $14.85 billion in FY2023 (+113.5%), $6.96 billion in FY2022 (-71.0%) and $24.02 billion in FY2021 (+197.6%).
- Quarterly Net Income towards Common Stockholders has ranged from $1.47 billion in Q4 2022 to $16.31 billion in Q4 2021 over the past five years.
- On a year-over-year basis, Net Income towards Common Stockholders rose in five of the last eight quarters, with growth averaging 28.9%.
- Peak year-over-year performance for Net Income towards Common Stockholders in the last five years was growth of 676.8% in Q4 2021, against a decline of 91.0% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.68 billion (Q1 2026), $2.26 billion (Q4 2025) and $6.57 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.24 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 653.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Bn |
| Mar 31, 2026 | 3.68 Bn |
| Dec 31, 2025 | 2.26 Bn |
| Sep 30, 2025 | 6.57 Bn |
| Jun 30, 2025 | 4.04 Bn |
| Mar 31, 2025 | 3.65 Bn |
| Dec 31, 2024 | 4.19 Bn |
| Sep 30, 2024 | 6.29 Bn |
| Jun 30, 2024 | 3.25 Bn |
| Mar 31, 2024 | 2.27 Bn |
| Dec 31, 2023 | 8.48 Bn |
| Sep 30, 2023 | 1.76 Bn |
| Jun 30, 2023 | 2.32 Bn |
| Mar 31, 2023 | 2.29 Bn |
| Dec 31, 2022 | 1.47 Bn |
| Sep 30, 2022 | 1.58 Bn |
| Jun 30, 2022 | 1.69 Bn |
| Mar 31, 2022 | 2.22 Bn |
| Dec 31, 2021 | 16.31 Bn |
| Sep 30, 2021 | 2.76 Bn |
API Access
Novartis Ag Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();